Literature DB >> 30345559

IL10 haplotypes are associated with diabetic nephropathy susceptibility in patients from western Mexico.

Luz E Chavarria-Buenrostro1, Jorge Hernandez-Bello2, Jose F Muñoz-Valle2, Jose Macias-Barragan3, Liliana B Hernandez-Carrillo1, Jorge F Topete-Reyes4, Renato Parra-Michel4, Maria G Ramirez-Dueñas1, Pedro E Sanchez-Hernandez1, Ana L Pereira-Suarez1, Eden Oceguera-Contreras3, Margarita Montoya-Buelna1.   

Abstract

INTRODUCTION: Diabetic Nephropathy (DN) is the main cause of chronic kidney disease (CKD) in diabetic patients. An IL-10 imbalance could be related to renal hypertrophy and trigger to nephropathy. Three promoter polymorphisms (-1082G>A, -819C>T, and -592C>A) at IL10 gene have been associated with changes in the IL-10 expression and DN susceptibility. Therefore, the aim of this study was to analyze this association in Mexican patients with DN.
METHODS: We conducted a case-control study on 128 patients with DN and 150 control subjects (CS) from western Mexico. All patients were tested for IL10 polymorphisms by PCR-RFLP. Allele frequencies, genotypes, and haplotypes were compared between groups. The significant haplotypes were correlated with patient clinical features.
RESULTS: IL10 gene ATC haplotype (-1082A/-819T/-592C) was found significantly more frequent in DN patients than in CS (P < 0.001; OR = 3.6, 95% CI: 1.7-7.4). Similarly GTA (-1082G/-819T/-592A) haplotype was more frequent in DN patients than CS with significant differences (P < 0.05; OR = 4.02, 95% CI: 1.10-14.78). There were no correlations between IL10 haplotypes and clinical parameters in patients with DN. However, that there is a trend of higher serum urea levels and lower eGFR in ATC haplotype carriers compared to carriers of the other haplotypes (P < 0.05).
CONCLUSIONS: These results indicate that IL10 promoter haplotypes ATC and GTA carriers have a higher risk factor to develop DN in the western Mexican population.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  IL10 haplotypes; IL10 polymorphisms; diabetic nephropathy; glomerular filtration rate; haplotype

Mesh:

Substances:

Year:  2018        PMID: 30345559      PMCID: PMC6818616          DOI: 10.1002/jcla.22691

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  28 in total

Review 1.  Genetic association studies: design, analysis and interpretation.

Authors:  Cathryn M Lewis
Journal:  Brief Bioinform       Date:  2002-06       Impact factor: 11.622

Review 2.  2. Classification and Diagnosis of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.

Authors:  Ying Wang; Maggie C Y Ng; Wing-Yee So; Ronald Ma; Gary T C Ko; Peter C Y Tong; Juliana C N Chan
Journal:  Nephrol Dial Transplant       Date:  2005-09-02       Impact factor: 5.992

Review 5.  Role of IL-10 in the progression of kidney disease.

Authors:  Inna Sinuani; Ilia Beberashvili; Zhan Averbukh; Judith Sandbank
Journal:  World J Transplant       Date:  2013-12-24

6.  Analysis of IL10 haplotypes in primary Sjögren's syndrome patients from Western Mexico: Relationship with mRNA expression, IL-10 soluble levels, and autoantibodies.

Authors:  M Vázquez-Villamar; C A Palafox-Sánchez; J F Muñoz-Valle; Y Valle; G Orozco-Barocio; J Hernández-Bello; E Oregon-Romero
Journal:  Hum Immunol       Date:  2015-06-12       Impact factor: 2.850

7.  Association between interleukin-10 gene polymorphisms and susceptibility to diabetic nephropathy in a Chinese population.

Authors:  D H Ma; Q Y Xu; Y Liu; Q Q Zhai; M H Guo
Journal:  Genet Mol Res       Date:  2016-05-09

8.  Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.

Authors:  Nabil Mtiraoui; Intissar Ezzidi; Maha Kacem; Manel Ben Hadj Mohamed; Molka Chaieb; Aoutef Bel Haj Jilani; Touhami Mahjoub; Wassim Y Almawi
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

9.  Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies.

Authors:  Xiaohai Zhang; Nancy L Reinsmoen
Journal:  Hum Immunol       Date:  2017-09-09       Impact factor: 2.850

Review 10.  Classification and Differential Diagnosis of Diabetic Nephropathy.

Authors:  Chenyang Qi; Xing Mao; Zhigang Zhang; Huijuan Wu
Journal:  J Diabetes Res       Date:  2017-02-20       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.